Drug has use and application. We can agree on that. Clearly short position as they have history shorting. Unfortunately they went all out on assault on character / playing on valid concerns. Fucked up move. I honestly hope this doesn’t effect shareholders heavily.
I want to see this drug hit the market; I’m sure many investors / patients do. But, that article was a serious low blow.... btw, I’ll change my pf pic back if I see considerate posts / no more noise